Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Vicarious Surgical Inc. (RBOT : NYSE)
 
 • Company Description   
Vicarious Surgical Inc. is a robotics company developing a disruptive technology. The Company's novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc., formerly known as D8 Holdings Corp., is headquartered in Waltham, Mass.

Number of Employees: 165

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.04 Daily Weekly Monthly
20 Day Moving Average: 368,474 shares
Shares Outstanding: 121.25 (millions)
Market Capitalization: $489.83 (millions)
Beta: -0.37
52 Week High: $15.40
52 Week Low: $3.05
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.18% 0.20%
12 Week -31.76% -28.15%
Year To Date -61.96% -55.66%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
78 FOURTH AVENUE
-
WALTHAM,MA 02451
USA
ph: 617-868-1700
fax: -
ir@vicarioussurgical.com http://www.vicarioussurgical.com
 
 • General Corporate Information   
Officers
Adam Sachs - Chief Executive Officer; President and Director
David Styka - Chairman of the Board
William Kelly - Chief Financial Officer and Treasurer
Sammy Khalifa - Chief Technology Officer and Director
June Morris - Chief Legal Officer; General Counsel and Secretary

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 92561V109
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 121.25
Most Recent Split Date: (:1)
Beta: -0.37
Market Capitalization: $489.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.82
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -116.85
12/31/21 - -198.54
09/30/21 - -
ROA
03/31/22 - -29.32
12/31/21 - -19.12
09/30/21 - -
Current Ratio
03/31/22 - 25.17
12/31/21 - 28.56
09/30/21 - 61.49
Quick Ratio
03/31/22 - 25.17
12/31/21 - 28.56
09/30/21 - 61.49
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 1.06
12/31/21 - 0.70
09/30/21 - 0.08
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.01
09/30/21 - 0.09
Debt-to-Capital
03/31/22 - 0.41
12/31/21 - 0.81
09/30/21 - 7.98
 

Powered by Zacks Investment Research ©